News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
MOORE ALISON
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/24/2023 |
4
| MOORE ALISON (Chief Technical Officer) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Granted 558,094 shares
@ $0
Granted 432,738 options to buy
@ $5.04, valued at
$2.2M
|
|
| 03/16/2023 |
4
| MOORE ALISON (Chief Technical Officer) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 8,351 shares
@ $5.5071, valued at
$46k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2022 |
4
| MOORE ALISON (Chief Technical Officer) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Granted 737,179 options to buy
@ $9.69, valued at
$7.1M
|
|
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2020 |
4
| MOORE ALISON (Chief Technical Officer) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Sold 24,233 shares
@ $42, valued at
$1M
Sold 11,031 shares
@ $42, valued at
$463.3k
Exercised 24,233 options to buy
@ $2.27, valued at
$55k
Exercised 11,031 options to buy
@ $2.27, valued at
$25k
|
|
| 10/09/2020 |
4
| MOORE ALISON (Chief Technical Officer) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Sold 5,065 shares
@ $41, valued at
$207.7k
Sold 39,509 shares
@ $41, valued at
$1.6M
Exercised 5,065 options to buy
@ $2.27, valued at
$11.5k
Exercised 30,199 options to buy
@ $2.27, valued at
$68.6k
|
|
| 10/08/2020 |
4
| MOORE ALISON (Chief Technical Officer) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Sold 44,574 shares
@ $40, valued at
$1.8M
Exercised 35,264 options to buy
@ $2.27, valued at
$80k
|
|
| 08/14/2020 |
4
| MOORE ALISON (Chief Technical Officer) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Exercised 32,451 options to buy
@ $2.27, valued at
$73.7k
|
|
| 06/18/2020 |
4
| MOORE ALISON (Director) has filed a Form 4 on CODEXIS, INC.|
Txns:
| Granted 17,905 shares
@ $0 |
|
| 06/16/2020 |
3
| MOORE ALISON (Director) has filed a Form 3 on CODEXIS, INC. |
| 03/20/2020 |
4
| MOORE ALISON (Chief Technical Officer) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Granted 30,800 shares
@ $0
Granted 109,600 options to buy
@ $18.22, valued at
$2M
|
|
| 03/18/2020 |
4
| MOORE ALISON (Chief Technical Officer) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Sold 3,750 shares
@ $19.1947, valued at
$72k
|
|
| 09/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2019 |
4
| MOORE ALISON (Chief Technical Officer) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Sold 47,205 shares
@ $26.7441, valued at
$1.3M
Sold 1,623 shares
@ $27.3069, valued at
$44.3k
Exercised 48,828 options to buy
@ $2.27, valued at
$110.8k
|
|
| 03/15/2019 |
4
| MOORE ALISON (Chief Technical Officer) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Granted 37,050 shares
@ $0
Granted 83,500 options to buy
@ $26.89, valued at
$2.2M
|
|
| 10/10/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|